A new pill for eczema is in final trials and showing great promise! Abrocitinib is a JAK inhibitor that is in phase three trials and seems to beeffective and with a reasonable safety profile. Stay tuned!
posted: Nov. 25, 2019.
A new pill for eczema is in final trials and showing great promise! Abrocitinib is a JAK inhibitor that is in phase three trials and seems to beeffective and with a reasonable safety profile. Stay tuned!
Monday:
8:00 am-5:00 pm
Tuesday:
8:00 am-5:00 pm
Wednesday:
8:00 am-5:00 pm
Thursday:
8:00 am-5:00 pm
Friday:
8:00 am-5:00 pm
Saturday:
Closed
Sunday:
Closed